Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Affect is a private U.S. digital behavioral health company that delivers virtual treatment for substance use disorders and mental health conditions through a smartphone app. The company combines therapy, psychiatric care, medication management, peer support, contingency management rewards, and progress tracking in a payer-covered telehealth model. Affect began with addiction treatment and has expanded from stimulant, alcohol, cannabis, and opioid use disorder programs into broader mental health services including anxiety and depression care. The business operates as a licensed, CARF-accredited provider in the states it serves and partners with insurers, providers, courts, employers, and health systems to expand access to outpatient and intensive outpatient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Affect.